{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:34:34Z","timestamp":1791117274611,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/bf03033916","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:54:14Z","timestamp":1248112454000},"page":"205-208","source":"Crossref","is-referenced-by-count":4,"title":["Sodium valproate does not augment Prpsc in murine neuroblastoma cells"],"prefix":"10.1007","volume":"12","author":[{"given":"Christophe","family":"Legendre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domnique","family":"Dormont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Clayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03033916_CR1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nbt855","volume":"21","author":"S Bach","year":"2003","unstructured":"Bach S, N Talarek, T Andrieu, JM Vierfond, Y Mettey, H Galons, D Dormont, L Meijer, C Cullin and M Blondel (2003) Isolation of drugs active against mammalian prions using a yeast-based screening assay.Nat. Biotechnol. 21, 1075\u20131081.","journal-title":"Nat. Biotechnol."},{"key":"BF03033916_CR2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/emboj\/21.5.1031","volume":"21","author":"GS Baron","year":"2002","unstructured":"Baron GS, K Wehrly, DW Dorward, B Chesebro and B Caughey (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(sc)) into contiguous membranes.EMBO J. 21, 1031\u20131040.","journal-title":"EMBO J."},{"key":"BF03033916_CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/med.10017","volume":"22","author":"RA Blaheta","year":"2002","unstructured":"Blaheta RA and J Cinatl Jr (2002) Anti-tumor mechanisms of valproate: a novel role for an old drug.Med. Res. Rev. 22, 492\u2013511.","journal-title":"Med. Res. Rev."},{"key":"BF03033916_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/66.1.109","volume":"66","author":"B Caughey","year":"2003","unstructured":"Caughey B (2003) Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.Br. Med. Bull. 66, 109\u2013120.","journal-title":"Br. Med. Bull."},{"key":"BF03033916_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-3233(01)57021-7","volume":"57","author":"B Caughey","year":"2001","unstructured":"Caughey B, GJ Raymond, MA Callahan, C Wong, GS Baron and LW Xiong (2001) Interactions and conversions of prion protein isoforms.Adv. Protein Chem. 57, 139\u2013169.","journal-title":"Adv. Protein Chem."},{"key":"BF03033916_CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/mcne.2002.1117","volume":"20","author":"AC Hall","year":"2002","unstructured":"Hall AC, A Brennan, RG Goold, K Cleverley, FR Lucas, PR Gordon-Weeks and PC Salinas (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.Mol. Cell. Neurosci. 20, 257\u2013270.","journal-title":"Mol. Cell. Neurosci."},{"key":"BF03033916_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-2952(03)00187-4","volume":"66","author":"AJ Harwood","year":"2003","unstructured":"Harwood AJ and G Agam (2003) Search for a common mechanism of mood stabilizers.Biochem. Pharmacol. 66, 179\u2013189.","journal-title":"Biochem. Pharmacol."},{"key":"BF03033916_CR8","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","volume":"98","author":"C Korth","year":"2001","unstructured":"Korth C, BC May, FE Cohen and SB Prusiner (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.Proc. Natl. Acad. Sci. USA 98, 9836\u20139841.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033916_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W Loscher","year":"2002","unstructured":"Loscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.CNS Drugs 16, 669\u2013694.","journal-title":"CNS Drugs"},{"key":"BF03033916_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj20021596","volume":"372","author":"M Perez","year":"2003","unstructured":"Perez M, AI Rojo, F Wandosell, J Diaz-Nido and J Avila (2003) Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.Biochem. J. 372, 129\u2013136.","journal-title":"Biochem. J."},{"key":"BF03033916_CR11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.10298","volume":"52","author":"GM Shaked","year":"2002","unstructured":"Shaked GM, R Engelstein, I Avraham, H Rosenmann and R Gabizon (2002) Valproic acid treatment results in increased accumulation of prion proteins.Ann. Neurol. 52, 416\u2013420.","journal-title":"Ann. Neurol."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033916\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:44:52Z","timestamp":1558572292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BF03033916"],"URL":"https:\/\/doi.org\/10.1007\/bf03033916","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}